Viewing Study NCT04464967


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-02 @ 11:06 AM
Study NCT ID: NCT04464967
Status: WITHDRAWN
Last Update Posted: 2021-05-12
First Post: 2020-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
Sponsor: NKGen Biotech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module